Lilly's Field Of Dreams: "Campaign For Modern Medicines" Wants A Clean PDUFA
Executive Summary
A pharma-sponsored group is actively pushing what many think may be an impossible task: passing the Prescription Drug User Fee reauthorization without any add-ons from Congress.
You may also be interested in...
PDUFA Word Association: Consumer Advocates Complain About Lack Of "Safety" In Commitment Letter
FDA’s Oct. 24 public meeting on the renewal of its drug user fee program demonstrated just how strong a position the agency is in regarding the renewal of the Rx part of the “UFA” legislation – most of the complaints were semantic, quite literally.
PDUFA Word Association: Consumer Advocates Complain About Lack Of "Safety" In Commitment Letter
FDA’s Oct. 24 public meeting on the renewal of its drug user fee program demonstrated just how strong a position the agency is in regarding the renewal of the Rx part of the “UFA” legislation – most of the complaints were semantic, quite literally.
PDUFA V Commitment Letter Front-Loads Guidance, Meeting Milestones
It may not feel like it to exhausted user fee negotiators, but the release of FDA’s draft commitment letter for PDUFA V signals the start of more long campaigns for the agency and pharmaceutical companies.